Relationship of Troponin I with Neutrophil Lymphocyte Ratio and Serum Amyloid A in Acute Coronary Syndrome
Keywords:Acute coronary syndrome, Neutrophil lymphocyte ratio, Serum amyloid A, Troponin
Introduction: Acute coronary syndrome (ACS) is the leading cause of death in the world. Acute myocardial infarction can initiate an acute inflammatory process by inducing pro-inflammatory cytokines at the cellular level measured by NLR, at the biomolecular level characterized by SAA production in liver. The relationship of elevated troponin I levels as a marker of myocardial necrosis with NLR and SAA as inflammatory markers need further discussion. The purpose of this study was to determine the relationship between cardiac necrosis markers and inflammatory parameters in ACS.
Methods: An analytic observational study with a cross-sectional approach was conducted from March to May 2019. This study involved 32 patients with ACS at the Emergency Department of Dr.Kariadi Hospital, with the onset of attacks of 4-6 hours which met the inclusion and exclusion criteria. Examination of troponin I level was done using the ELFA method, NLR value was measured using a hematology analyzer, and SAA level was measured using the ELISA method. Statistical test was done using Spearman correlation. Value of p < 0.05 was considered significant.
Results: The median (min-max) of troponin I, NLR, and SAA values were 0.617 (0.001-40,000) μg/L, 4.92 (1.38-18.16) and 40.454 (5.879-66.059) μg/ml, respectively. The correlation of troponin I level with NLR and SAA were r=0.180, p=0.243 and r=0.655, p=0.000.
Conclusions: There was a significant positive moderate relationship between troponin I level and SAA which could be used as a marker of acute inflammation in ACS, whereas cell inflammation marker of NLR did not provide a significant meaning.
Keywords: ACS, NLR, SAA, troponin
Plum Analytics Artifact Widget Block
Che-Muzaini CM, Norsa’adah B. Complications of acute coronary syndrome in young patients. Iran J Public Health. 2017;46(1):139-40. PMid:28451542
Shakya A, Jha SC, Gajurel RM, Poudel CM, Sahi R, Shresta H, et al. Clinical characteristics, risk factors and angiographic profile of acute coronary syndrome patients in a tertiary care center of Nepal. Nepalese Heart J. 2019;16(1):27-32. https://doi.org/10.3126/njh.v16i1.23895 DOI: https://doi.org/10.3126/njh.v16i1.23895
Esteban MR, Montero SM, Sanchez JJ, Hernandez HP, Rerez JJ, Afonso JH, et al. Acute coronary syndrome in the young: Clinical characteristics, risk factor and prognosis. Open Cardiovasc Med J. 2014;8:61-7. Mid:25152777 DOI: https://doi.org/10.2174/1874192401408010061
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: Executive summary, a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;130(25):2354-94. https://doi.org/10.1161/cir.0000000000000133 Mid:25249586 DOI: https://doi.org/10.1161/CIR.0000000000000133
Targońska-Stępniak B, Majdan M. Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis. Mediators Inflamm. 2014;2014:793628. https://doi.org/10.1155/2014/793628 PMid:25525305 DOI: https://doi.org/10.1155/2014/793628
Siegmund SV, Schlosser M, Schildberg FA, Seki E, Minicis SD, Uchinami H, et al. Serum amyloid a induces inflammation, proliferation and cell death in activated hepatic stellate cells. PLoS One. 2016;11(3):1-17. https://doi.org/10.1371/journal.pone.0150893 PMid:26937641 DOI: https://doi.org/10.1371/journal.pone.0150893
Sudana IN, Setyawati, Sukorini U. Significant differences in amyloid serum a levels between coronary stenosis and non-coronary stenosis. Indones J Clin Pathol. 2015;21(3):231-6. https://doi.org/10.24293/ijcpml.v21i3.1273 DOI: https://doi.org/10.24293/ijcpml.v21i3.1273
Della-Bona R, Cardillo MT, Leo M, Biasillo G, Gustapane M, Trotta F, et al. Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: A causative role? Inflamm Res. 2013;62(6):537-50. https://doi.org/10.1007/s00011-013-0617-0 PMid:23549741 DOI: https://doi.org/10.1007/s00011-013-0617-0
Bajari R, Tak S. Predictive prognostic value of neutrophil-lymphocytes ratio in acute coronary syndrome. Indian Heart J. 2017;69(Suppl 1):S46-50. https://doi.org/10.1016/j.ihj.2017.01.020 PMid:28400038 DOI: https://doi.org/10.1016/j.ihj.2017.01.020
Ionita MG, van den Borne P, Catanzariti LM, Moll FL, de Vries JP, Pasterkamp G, et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol. 2010;30(9):1842-8. https://doi.org/10.1161/atvbaha.110.209296 PMid:20595650 DOI: https://doi.org/10.1161/ATVBAHA.110.209296
Nalbant A, Cinemre H, Kaya T, Varim C, Varim P, Tamer A. Neutrophil to lymphocyte ratio might help prediction of acute myocardial infarction in patients with elevated serum creatinine. Pak J Med Sci. 2016;32(1):106-10. https://doi.org/10.12669/pjms.321.8712 PMid:27022355 DOI: https://doi.org/10.12669/pjms.321.8712
Korkmaz A, Yildic A, Gunes H, Duyuler S, Tunces A. Utility of neutrophil lymphocyte ratio in predicting troponin elevation in the emergency department setting. Clin Appl Thromb Hemost. 2015;21(7):667-71. https://doi.org/10.1177/1076029613519850 PMid:24431379 DOI: https://doi.org/10.1177/1076029613519850
Tahto E, Jadric R, Pojskic L, Kicic E. Neutrophil to lymphocyte ratio and its relation with markers of inflammation and myocardial necrosis in patient with acute coronary syndrome. Med Arch. 2017;71(5):312-15. https://doi.org/10.5455/medarh.2017.71.312-315 PMid:29284896 DOI: https://doi.org/10.5455/medarh.2017.71.312-315
Nugroho A, Suwarman, Nawawi AM. Relationship between neutrophil lymphocyte ratio and sequencial organ failure score in the intensive care unit. J Anest Periop. 2013;1(3):189-96. https://doi.org/10.15851/jap.v1n3.198 DOI: https://doi.org/10.15851/jap.v1n3.198
Lee AJ, Suksuh H, Jeon CH, Kim SG. Effects of one directional pneumatic tube system on routine hematology and chemistry parameters: A validation study at a tertiary care hospital. Pract Lab Med. 2017;9:12-7. https://doi.org/10.1016/j.plabm.2017.07.002 PMid:29034301 DOI: https://doi.org/10.1016/j.plabm.2017.07.002
Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease. Tex Heart Inst J. 2013;40:17-29. PMid:23467296
Lin BD, Montoro EC, Bell JT, Boomsma DI, Geus EJ, Jansen R, et al. SNP heritability and effects of genetic variants for neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio. J Hum Genet. 2017;62(11):979-88. https://doi.org/10.1038/jhg.2017.76 PMid:29066854 DOI: https://doi.org/10.1038/jhg.2017.76
Rosales C. Neutrophil: A cell with many roles in inflammation or several cell types? Front Physiol. 2018;9:113. https://doi.org/10.3389/fphys.2018.00113 PMid:29515456 DOI: https://doi.org/10.3389/fphys.2018.00113
Kumar S, Dikshit M. Metabolic insight of neutrophils in health and disease. Front Immunol. 2019;10:2099. https://doi.org/10.3389/fimmu.2019.02099 PMid:31616403 DOI: https://doi.org/10.3389/fimmu.2019.02099
Zairis MN, Lyras AG, Bibis GP, Patsourakos NG, Makrygiannis SS, Kardoulas AD, et al. Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST elevation acute myocardial infarction. Atherosclerosis. 2005;182(1):161-7. https://doi.org/10.1016/j.atherosclerosis.2005.01.039 PMid:16115487 DOI: https://doi.org/10.1016/j.atherosclerosis.2005.01.039
Cabala M, Gajdosz R. The role of serum amyloid A in the early diagnosis of acute coronary syndrome. Przegl Lek. 2005;62(1):13-6. PMid:16053213
Malle E, De-Beer FC. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996;26(6):427-35. https://doi.org/10.1046/j.1365-2362.1996.159291.x PMid:8817153 DOI: https://doi.org/10.1046/j.1365-2362.1996.159291.x
Kotani K, Satoh N, Yamada T, Gugliucci A. The potential of serum amyloid A-LDL as a novel biomarker for cardiovascular disease risk. Clin Lipidol. 2010;5:489-95. https://doi.org/10.2217/clp.10.42 DOI: https://doi.org/10.2217/clp.10.42
How to Cite
Copyright (c) 2022 Edward Kurnia Setiawan Limijadi, Inggrid Lovita, Imam Budiwijono, Ariosta Setyadi, Sulistiyati Bayu Utami, Buwono Puruhito, Sefri Noventi Sofia (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.